107 related articles for article (PubMed ID: 30121621)
1. Molecular basis of distinct oestrogen responses in endometrial and breast cancer.
Baxter E; Windloch K; Kelly G; Lee JS; Gannon F; Brennan DJ
Endocr Relat Cancer; 2019 Jan; 26(1):31-46. PubMed ID: 30121621
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors.
Droog M; Nevedomskaya E; Dackus GM; Fles R; Kim Y; Hollema H; Mourits MJ; Nederlof PM; van Boven HH; Linn SC; van Leeuwen FE; Wessels LF; Zwart W
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1316-E1325. PubMed ID: 28167798
[TBL] [Abstract][Full Text] [Related]
3. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
4. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.
Droog M; Nevedomskaya E; Kim Y; Severson T; Flach KD; Opdam M; Schuurman K; Gradowska P; Hauptmann M; Dackus G; Hollema H; Mourits M; Nederlof P; van Boven H; Linn SC; Wessels L; van Leeuwen FE; Zwart W
Cancer Res; 2016 Jul; 76(13):3773-84. PubMed ID: 27197147
[TBL] [Abstract][Full Text] [Related]
5. The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.
Wortham NC; Ahamed E; Nicol SM; Thomas RS; Periyasamy M; Jiang J; Ochocka AM; Shousha S; Huson L; Bray SE; Coombes RC; Ali S; Fuller-Pace FV
Oncogene; 2009 Nov; 28(46):4053-64. PubMed ID: 19718048
[TBL] [Abstract][Full Text] [Related]
6. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract][Full Text] [Related]
7. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.
Chen Z; Yang HJ; Lin Q; Zhu MJ; Yu YY; He XY; Wan XP
Cell Commun Signal; 2020 Jun; 18(1):84. PubMed ID: 32503542
[TBL] [Abstract][Full Text] [Related]
9. Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.
Pan Y; Shi J; Ni W; Liu Y; Wang S; Wang X; Wei Z; Wang A; Chen W; Lu Y
J Cell Mol Med; 2017 Sep; 21(9):2129-2139. PubMed ID: 28272775
[TBL] [Abstract][Full Text] [Related]
10. Estrogen signaling and unfolded protein response in breast cancer.
Rajapaksa G; Thomas C; Gustafsson JÅ
J Steroid Biochem Mol Biol; 2016 Oct; 163():45-50. PubMed ID: 27045680
[TBL] [Abstract][Full Text] [Related]
11. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
12. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
13. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
[TBL] [Abstract][Full Text] [Related]
14. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
[TBL] [Abstract][Full Text] [Related]
15. Activation of rapid oestrogen signalling in aggressive human breast cancers.
Poulard C; Treilleux I; Lavergne E; Bouchekioua-Bouzaghou K; Goddard-Léon S; Chabaud S; Trédan O; Corbo L; Le Romancer M
EMBO Mol Med; 2012 Nov; 4(11):1200-13. PubMed ID: 23065768
[TBL] [Abstract][Full Text] [Related]
16. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
17. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
18. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
[TBL] [Abstract][Full Text] [Related]
19. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
[TBL] [Abstract][Full Text] [Related]
20. Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.
Lin CY; Chao A; Wang TH; Lee LY; Yang LY; Tsai CL; Wang HS; Lai CH
Oncotarget; 2016 Sep; 7(37):60038-60052. PubMed ID: 27527851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
